Funder: Patient-Centered Outcomes Research Institute

Due Dates (Anticipated): September 2026 (Letter of Intent) | January 2027 (Full application)

Funding Amounts: Up to $12 million in direct costs per project (max 5 years); total program budget up to $60 million.

Summary: Supports high-impact, patient-centered comparative effectiveness research addressing care, symptom management, and diagnosis challenges in rare diseases.

Key Information: All dates are projected; verify on the program page for updates.